What is the serial number for ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%?

The USPTO serial number for ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% is 87784530.

What is the registration number for ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%?

ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% is registered under USPTO registration number 0.

ONC

USPTO Trademark Record

ABANDONED

ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

Q: Who owns the ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% trademark?

The ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% trademark is owned by Aerie Pharmaceuticals, Inc..

Q: What class is the ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% trademark registered in?

The ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

SN 87784530·Reg 0·Filed Feb 05, 2018

Owner Aerie Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% (Serial No. 87784530), Registration No. 0, is a abandoned US trademark filed on Feb 05, 2018 by Aerie Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% (Reg. #0) is an abandoned US trademark that was filed in 2018 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 05, 2018

SERIAL

87784530

REG#

Owner

Applicant

Aerie Pharmaceuticals, Inc.

Entity

Corporation

State

Address

2030 Main Street, Suite 1500, Irvine, CA, 92688

Country

Attorney

NameMelissa W. Woo-Allen

Law firm

Melissa W. Woo-Allen WOO ALLEN LAW LLP

Docket

Aerie

Address

3398 Carmel Mountain Road, Ste. 250, SAN DIEGO, CA 92121, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateFeb 05, 2018

Serial Number87784530

Registration No.0

Status DateApr 19, 2021

Published for OppositionJan 22, 2019

Mark TypeDesign with words

Attorney DocketAerie

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

36 events

ABANDONMENT - NO USE STATEMENT FILED

Apr 19, 2021

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Apr 19, 2021

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 15, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

Sep 11, 2020

SOU EXTENSION 3 GRANTED

SOU EXTENSION 3 FILED

Sep 11, 2020

SOU EXTENSION 3 FILED

SOU TEAS EXTENSION RECEIVED

Sep 11, 2020

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 14, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Mar 12, 2020

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Mar 12, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Mar 12, 2020

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 09, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 08, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 GRANTED

Nov 08, 2019

SOU EXTENSION 1 GRANTED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 21, 2019

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOTICE OF REVIVAL - E-MAILED

Oct 21, 2019

NOTICE OF REVIVAL - E-MAILED

SOU EXTENSION RECEIVED WITH TEAS PETITION

Oct 21, 2019

SOU EXTENSION RECEIVED WITH TEAS PETITION

PETITION TO REVIVE-GRANTED

Oct 21, 2019

PETITION TO REVIVE-GRANTED

ABANDONMENT - NO USE STATEMENT FILED

Oct 21, 2019

ABANDONMENT - NO USE STATEMENT FILED

TEAS PETITION TO REVIVE RECEIVED

Oct 21, 2019

TEAS PETITION TO REVIVE RECEIVED

SOU EXTENSION 1 FILED

Sep 19, 2019

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 19, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 22, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Jan 22, 2019

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 02, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 12, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 12, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 12, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Dec 04, 2018

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 28, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 28, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

May 28, 2018

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 28, 2018

NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 18, 2018

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Feb 14, 2018

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 13, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 08, 2018

NEW APPLICATION ENTERED

ONCE-DAILY RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Aerie Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Melissa W. Woo-Allen

Resources

Company